ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Clinical and Diagnostic Microbiology and Immunology
This article is part of the Research TopicTransmission Dynamics and Population Genomics of Superbug Pathogens of Public Health ImportanceView all 9 articles
Genomic epidemiological analysis reveals new insights into the resurgence of Mycoplasma pneumoniae in China
Provisionally accepted- 1Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng, China
- 2Beijing Center for Disease Prevention and Control (Beijing CDC), Beijing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objectives: After coronavirus disease 2019 pandemic restrictions, Mycoplasma pneumoniae (M. pneumoniae) re-surged widely across the world. To determine the genomic epidemiological characteristics of resurging M. pneumoniae, which has dominated the respiratory infection outbreak in Beijing, China, since mid-September 2023. Methods: M. pneumoniae samples were collected from patients with acute respiratory-tract infections in Beijing in 2018–2023. A total of 160 M. pneumoniae genomes were sequenced via probe-capture-based approach. The genetic features of M. pneumoniae were characterized by multilocus sequence typing and comparative genomic analysis. Results: In total, 160 patients with M. pneumoniae infections were enrolled. ST3 (n = 93) and ST14 (n = 65) were the predominant sequence types. The macrolide-resistant mutation rate of ST3 was maintained at 100%, whereas that of ST14 increased rapidly. Comparative genomic analysis revealed 99% to > 99% similarity among the Beijing strains from 2023 when aligned to the reference M129 genome. The major variation occurs in the P1 gene. MAUVE indicated a lack of rearrangement, yet it included four subtype-specific insertions and non-conserved hsdS genes. The phylogenetic tree showed that strains from Asia and other world regions clustered into distinct clades, with significant evolutionary differences. Further genomic analyses identified some Asia-dominant genetic variations in genes associated with genome stability, pathogenesis, and drug resistance. Conclusions: The 2023 outbreak of M. pneumoniae was not attributable to a novel variant but stemmed from the resurgence of the pre-existing strains. Our genomic epidemiological findings demonstrated that the endemic strains in different regions exhibit distinct genomic characteristics, associated with genomic stability.
Keywords: Mycoplasma pneumoniae, macrolide resistance, genomic epidemiological analysis, Genetic Variation, Comparative genomics
Received: 14 Apr 2025; Accepted: 27 Oct 2025.
Copyright: © 2025 Wang, Zheng, Gong, Luo, Li, Duan, Wang, Hu, Guan, Yang, Huang and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Fan Yang, ymf129@163.com
Fang Huang, hhffxdd@126.com
Lihong Chen, chenlh@ipbcams.ac.cn
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
